1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide,
KMD 3213,
KMD-3213,
rapaflo,
silodosin,
Silodosin,
160970-54-7,
Rapaflo,
Urief,
Silodyx,
Urorec,
KMD-3213,
KMD 3213,
Silodosin-d6,
UNII-CUZ39LUY82,
KAD 3213,
CUZ39LUY82,
CHEMBL24778,
KAD-3213,
(R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide,
1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide,
Q-102517,
Rapflo,
1H-Indole-7-carboxamide, 2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-,
2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide,
Silodosin [INN:BAN],
160970-64-9,
Silodosin(Rapaflo),
(R)-1-(3-Hydroxypropyl)-5-[2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]indoline-7-carboxamide,
Rapaflo (TN),
Silodosin (Rapaflo),
Urief (TN),
Silodosin (R-isomer),
Silodosin (JP17/INN),
AC1NSM20,
GTPL493,
MLS006010022,
SCHEMBL136973,
Silodosin, >=98% (HPLC),
DTXSID40167045,
KMD3213,
C25H32F3N3O4,
CHEBI:135929,
PNCPYILNMDWPEY-QGZVFWFLSA-N,
HMS3715B06,
BCP02143,
EBD33557,
KSO-0400,
ZINC3806063,
ABP000202,
AN-927,
BDBM50160154,
CS0060,
MFCD00930170,
s1613,
AKOS005145899,
API0006406,
BS-1011,
CCG-221202,
CS-0284,
DB06207,
RL02066,
SB19320,
KAD-3213, KMD-3213,
1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide,
AC-22605,
HY-10122,
SC-22125,
SMR004701206,
AB0009977,
DB-064382,
Silodosin(Rapaflo)/KAD 3213,KMD 3213,
AM20090780,
FT-0674584,
FT-0687491,
SW219765-1,
D01965,
W-5225,
970S649,
A810210,
SR-01000944157,
I14-8796,
SR-01000944157-1,
I14-33112,
( C)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide,
(-)-1-(3-Hydroxypropyl)-5-((2R)-2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide,
(_)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide,
(R)-5-[2-[[2-[2-(2,2,2-trifluoro-ethoxy)phenoxy]ethyl]amino]propyl]-1-(3-hydroxypropyl)-2,3-dihydro-1H-indole-7-carboxamide,
1-(3-Hydroxy-propyl)-5-((R)-2-{2-[2-(2,2,2-trifluoro-ethoxy)-phenoxy]-ethylamino}-propyl)-2,3-dihydro-1H-indole-7-carboxylic acid amide,
1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]-ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide,
1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide,
1-(3-oxidanylpropyl)-5-[(2R)-2-[2-[2-[2,2,2-tris(fluoranyl)ethoxy]phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide,
silodoshin,
Silodosin [INN],
D0U0VU,
cc-327,
ACN-S002529,
CID5312125,
CS-O-11743,
A8521,
C095285,
Silodosin, 98%, an alpha1-adrenoceptor antagonist - 10MG 10mg,
1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide,
1051374-52-7,